Press Releases May 11, 2026 04:45 PM

Midland States Bancorp, Inc. Appoints Claire Stack Chief Financial Officer

Midland States Bancorp Appoints Claire Stack as Permanent Chief Financial Officer

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
MSBI

Midland States Bancorp, Inc. announced the appointment of Claire A. Stack as Executive Vice President and Chief Financial Officer, effective May 8, 2026. Having served as interim CFO since March 2026, Stack brings over 15 years of finance and accounting leadership experience in the financial services sector. The company underlines her role in providing stability and supporting strategic priorities as it continues to grow its financial organization.

Midland States Bancorp, Inc. Appoints Claire Stack Chief Financial Officer
MSBI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Claire A. Stack officially appointed as CFO after serving in interim role since March 2026.
  • Stack has more than 15 years of finance and accounting leadership experience, including public bank accounting and SEC reporting.
  • Midland States Bancorp manages $6.55 billion in assets and offers banking, credit card, trust, investment, insurance, and financial planning services.

EFFINGHAM, Ill. , May 11, 2026 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (Nasdaq: MSBI) (the “Company”) announced today that Claire A. Stack has been appointed Executive Vice President and Chief Financial Officer of the Company and Midland States Bank, its wholly-owned subsidiary (the “Bank”), effective May 8, 2026.

Jeff Ludwig, President and Chief Executive Officer of the Company, commented, “Claire has earned the trust of our organization through her strong leadership, collaborative approach, and deep financial expertise. Since stepping into the interim CFO role, she has provided stability and clear direction for our finance team. I’m excited to have her step into the role permanently as we continue building a high-performing, disciplined financial organization that supports our broader strategic priorities.”

Ms. Stack joined the Company in November 2025 as Corporate Controller and has served as Vice President – Chief Accounting Officer and interim Chief Financial Officer since March 2026. She brings more than fifteen years of accounting and finance leadership experience within the financial services sector, including public bank accounting, SEC reporting, internal controls, and audit and regulatory compliance. Ms. Stack is a Certified Public Accountant (CPA) and previously served as Corporate Controller at Steelcase, Inc., a publicly traded furniture company, and held various senior leadership positions in accounting and finance at CliftonLarsonAllen LLP, a public accounting firm, Agracel, Inc., an industrial real estate developer, PricewaterhouseCoopers LLP, and KPMG LLP. She holds a Bachelor of Science in Accounting and Technology Management from Indiana University’s Kelley School of Business.

About Midland States Bancorp, Inc.

Midland States Bancorp, Inc. is a community-based financial holding company headquartered in Effingham, Illinois, and is the sole shareholder of Midland States Bank. As of March 31, 2026, the Company had total assets of approximately $6.55 billion, and its Wealth Management Group had assets under administration of approximately $4.47 billion. The Company provides a full range of commercial and consumer banking products and services, merchant credit card services, trust and investment management, insurance and financial planning services. For additional information, visit midlandsb.com or follow Midland States Bank on LinkedIn.

CONTACTS:
Claire A. Stack, Chief Financial Officer, at cstack@midlandsb.com or (217) 342-7321


Risks

  • Transition risk related to leadership change though mitigated by Stack's interim experience.
  • Potential market volatility impacting financial services sector and bank asset values.
  • Regulatory and compliance risks inherent in financial institutions may affect performance.

More from Press Releases

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress Jun 14, 2026 Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 Jun 14, 2026 Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026 Jun 14, 2026 Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control Jun 14, 2026 Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026